FDA Recalls Batches of Levothyroxine Sodium Due to Quality Concerns

The FDA has recalled specific batches of levothyroxine sodium, a thyroid hormone replacement drug, after quality control checks revealed potential issues with the medicine's potency or stability. Inadequate dosing of levothyroxine can lead to altered disease control and symptoms such as fatigue, changes in heart rhythm, weight fluctuations, or nervousness.